疫苗犹豫可能真正的进步

Drew Altman的Axios栏利用了新的KFF COVID-19疫苗监测仪提供的数据,以评估该国在疫苗犹豫方面所处的位置。

阅读帖子

COVID-19导致健康支出下降

Drew Altman在其最新的Axios专栏中对冠状病毒大流行对国家卫生支出的影响进行了新的分析。

阅读帖子

出口民意调查显示在Red America中需要对抗COVID-19拒绝

Drew Altman在他最新的Axios专栏中分析了退出民意调查。尽管拜登选民将COVID-19列为重中之重,但特朗普的支持者仍然在很大程度上否认了流行病,否认了总统。

阅读帖子

乔·拜登(Joe Biden)在卫生保健问题上的重要领导

在Axios专栏中,Drew Altman讨论了选举年的健康状况不是一个单独的问题— but several —乔·拜登(Joe Biden)在所有这些方面都比特朗普总统更具优势,尽管反对ACA的反对派在特朗普的支持下仍然很受欢迎。  

阅读帖子

黑人美国人对冠状病毒疫苗更持怀疑态度

德鲁·奥特曼(Drew Altman)讨论了系统性种族主义如何导致令人震惊的不愿在包括高危人群在内的美国黑人中获得COVID-19疫苗的情况,以及它为结束大流行所带来的挑战。

阅读帖子

毒品阿仁’这是美国在医疗保健上投入这么多的原因

德鲁·奥特曼(Drew Altman)在Axios上的专栏文章:美国现在的人均支出是其他富裕国家在医疗保健方面的支出的两倍。但是,尽管毒品成本无时无刻不在公众辩论中,’医院和门诊的支出主要解释了差异。他说,如果没有真正的痛苦和政治风险,这将是不可能发生的。

阅读帖子
ES_WP_Query Object
(
    [es_map:protected] => Array
        (
            [post_meta] => post_meta.%s.raw
            [post_meta.analyzed] => post_meta.%s.value
            [post_meta.long] => post_meta.%s.long
            [post_meta.double] => post_meta.%s.double
            [post_meta.binary] => post_meta.%s.boolean
            [post_meta.date] => post_meta.%s.date
            [post_meta.datetime] => post_meta.%s.datetime
            [post_meta.time] => post_meta.%s.time
            [post_meta.signed] => post_meta.%s.long
            [post_meta.unsigned] => post_meta.%s.long
            [term_id] => terms.%s.term_id
            [term_slug] => terms.%s.slug
            [term_name] => terms.%s.name.raw
            [term_tt_id] => terms.%s.term_taxonomy_id
            [category_id] => terms.%s.term_id
            [category_slug] => terms.%s.slug
            [category_name] => terms.%s.name.raw
            [category_tt_id] => terms.%s.term_taxonomy_id
            [tag_id] => terms.%s.term_id
            [tag_slug] => terms.%s.slug
            [tag_name] => terms.%s.name.raw
            [tag_tt_id] => terms.%s.term_taxonomy_id
            [post_name] => post_name.raw
            [post_title] => post_title.raw
            [post_title.analyzed] => post_title
            [post_content.analyzed] => post_content
            [post_author] => post_author.user_id
            [post_date] => post_date.date
            [post_date_gmt] => post_date_gmt.date
            [post_modified] => post_modified.date
            [post_modified_gmt] => post_modified_gmt.date
            [post_type] => post_type.raw
        )

    [es_args] => Array
        (
            [query] => Array
                (
                    [bool] => Array
                        (
                            [filter] => Array
                                (
                                    [0] => Array
                                        (
                                            [terms] => Array
                                                (
                                                    [post_type.raw] => Array
                                                        (
                                                            [0] => perspective
                                                            [1] => page
                                                        )

                                                )

                                        )

                                    [1] => Array
                                        (
                                            [terms] => Array
                                                (
                                                    [post_status] => Array
                                                        (
                                                            [0] => publish
                                                        )

                                                )

                                        )

                                    [2] => Array
                                        (
                                            [bool] => Array
                                                (
                                                    [should] => Array
                                                        (
                                                            [0] => Array
                                                                (
                                                                    [term] => Array
                                                                        (
                                                                            [post_meta.kff_author.raw] => 49507
                                                                        )

                                                                )

                                                            [1] => Array
                                                                (
                                                                    [term] => Array
                                                                        (
                                                                            [post_meta.included_on_page.raw] => 105174
                                                                        )

                                                                )

                                                        )

                                                )

                                        )

                                )

                        )

                )

            [sort] => Array
                (
                    [0] => Array
                        (
                            [post_date.date] => desc
                        )

                )

            [_source] => Array
                (
                    [0] => post_id
                )

            [from] => 0
            [size] => 6
        )

    [es_response] => Array
        (
            [took] => 3
            [timed_out] => 
            [_shards] => Array
                (
                    [total] => 5
                    [successful] => 5
                    [skipped] => 0
                    [failed] => 0
                )

            [hits] => Array
                (
                    [total] => 255
                    [max_score] => 
                    [hits] => Array
                        (
                            [0] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 501146
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 501146
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1608008441000
                                        )

                                )

                            [1] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 499019
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 499019
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1606885229000
                                        )

                                )

                            [2] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 496309
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 496309
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1605589234000
                                        )

                                )

                            [3] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 491731
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 491731
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1603260242000
                                        )

                                )

                            [4] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 490123
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 490123
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1602654475000
                                        )

                                )

                            [5] => Array
                                (
                                    [_index] => kff.production
                                    [_type] => post
                                    [_id] => 486505
                                    [_score] => 
                                    [_source] => Array
                                        (
                                            [post_id] => 486505
                                        )

                                    [sort] => Array
                                        (
                                            [0] => 1601445909000
                                        )

                                )

                        )

                )

        )

    [query] => Array
        (
            [post_type] => Array
                (
                    [0] => perspective
                    [1] => page
                )

            [orderby] => date
            [order] => DESC
            [posts_per_page] => 6
            [paged] => 1
            [meta_query] => Array
                (
                    [relation] => OR
                    [0] => Array
                        (
                            [key] => kff_author
                            [value] => 49507
                        )

                    [1] => Array
                        (
                            [key] => included_on_page
                            [value] => 105174
                        )

                )

        )

    [query_vars] => Array
        (
            [post_type] => Array
                (
                    [0] => perspective
                    [1] => page
                )

            [orderby] => date
            [order] => desc
            [posts_per_page] => 6
            [paged] => 1
            [meta_query] => Array
                (
                    [relation] => OR
                    [0] => Array
                        (
                            [key] => kff_author
                            [value] => 49507
                        )

                    [1] => Array
                        (
                            [key] => included_on_page
                            [value] => 105174
                        )

                )

            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => 
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 
            [update_post_term_cache] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
        )

    [tax_query] => ES_WP_Tax_Query Object
        (
            [es_query:protected] => ES_WP_Query Object
 *RECURSION*
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => 
            [primary_id_column] => 
        )

    [meta_query] => ES_WP_Meta_Query Object
        (
            [es_query:protected] => ES_WP_Query Object
 *RECURSION*
            [queries] => Array
                (
                    [0] => Array
                        (
                            [key] => kff_author
                            [value] => 49507
                        )

                    [1] => Array
                        (
                            [key] => included_on_page
                            [value] => 105174
                        )

                    [relation] => OR
                )

            [relation] => OR
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                    [meta-clause] => Array
                        (
                            [key] => kff_author
                            [value] => 49507
                            [compare] => =
                            [type] => 
                        )

                    [meta-clause-1] => Array
                        (
                            [key] => included_on_page
                            [value] => 105174
                            [compare] => =
                            [type] => 
                        )

                )

            [has_or_relation:protected] => 1
            [queries_types_all] => Array
                (
                    [0] => Array
                        (
                            [key] => kff_author
                        )

                    [1] => Array
                        (
                            [key] => included_on_page
                        )

                )

        )

    [date_query] => 
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 501146
                    [post_author] => 36621681
                    [post_date] => 2020-12-15 05:00:41
                    [post_date_gmt] => 2020-12-15 10:00:41
                    [post_content] => 
A shorter version of this column has been published by Axios. There is a lot to be very worried about when it comes to vaccine hesitancy, but there are also reasons to be optimistic. The shares of hesitant groups that appear totally dug in are relatively modest for a new vaccine people have not seen administered safely in their communities, and many of the reasons people are reluctant to get vaccinated are remediable if they get more information from sources they trust. Four groups jump out from our new 肯德基COVID-19 Vaccine Monitor project as vaccine hesitant: Republicans and rural Americans – the Trump base, parroting the president’s COVID denialism; Black adults, and essential workers. In every case more members of each group says they will get the vaccine than say they will not. The shares who are currently hesitant range from 42% for Republicans to 33% for essential workers. Those are still big numbers, but it appears they can be reduced with more information. For example, 71% of Black adults who are now hesitant say it’s because they are worried about side effects. Once they learn they are mild and confirm that as people are vaccinated they may worry less. The same is true for the 50% of vaccine-hesitant Black adults who worry that they will actually get COVID from the vaccine, another top concern. 25% of Republicans currently say they will “definitely not” get the vaccine. But that leaves three quarters of Republicans who may get the vaccine under various circumstances: 28% of Republicans say they will get it “as soon as possible”; 33% want to “wait and see”; and 10% say they will get it “only if its required”. Among essential workers – a group that is a particularly important target of vaccination efforts because of their high risk of exposure to the virus – 28% say they will get the vaccine as soon as they can and 36% want to “wait and see”; another 14% say they’ll only get it if required for work or other activities, and 18% say they “definitely will not” get vaccinated. Hesitant essential workers have a variety of worries:  Half (51%) are worried about side effects, and a similar percentage don’t trust the government to make sure the vaccine is safe and effective (50%). There could be setbacks if there are adverse events that receive wide press coverage that spook already apprehensive groups and these will have to be managed well by public health leaders.  States will also need to allocate vaccine supply equitably to inner city and rural areas and assure distribution in those areas that is accessible for traditionally underserved populations. Distrust of government and institutions in communities of color will remain a real barrier. It will take effective messaging and information efforts utilizing credible messengers and digital communications techniques to reach these different groups, targeting their different worries about the vaccine. No one message or single messenger is likely to be effective. If those efforts are funded and implemented it does appear that real progress can be made to reduce hesitancy among the most resistant groups.
[post_title] => 疫苗犹豫可能真正的进步 [post_excerpt] => Drew Altman的Axios栏利用了新的KFF COVID-19疫苗监测仪提供的数据,以评估该国在疫苗犹豫方面所处的位置。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => real-progress-is-possible-on-vaccine-hesitancy [to_ping] => [pinged] => [post_modified] => 2020-12-22 14:00:22 [post_modified_gmt] => 2020-12-22 19:00:22 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=501146 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 499019 [post_author] => 36621681 [post_date] => 2020-12-02 05:00:29 [post_date_gmt] => 2020-12-02 10:00:29 [post_content] =>
A shorter version of this column has been published by Axios. We have never seen a year in which health spending actually goes down. Now the seemingly impossible is happening, but the reason – COVID-19 – makes it both anomalous and more tragic than a cause for celebration. + Year-to-date spending on health services is down about 2% from last year. Health spending for the calendar year may end up lower than it was in 2019. + Adding spending for drugs, which are less affected by COVID-19 and have not fallen, total health spending is still down by about 0.5% from last year. + At its low point in April when the pandemic first really hit, spending on health services had fallen an eye popping 32% on an annualized basis. + This is the first time expenditures for patient care have fallen year-over-year since data became available in the 1960s. The largest drop-offs were in outpatient care as people put off elective services or doctors offices and outpatient clinics shut down. Telehealth visits increased dramatically but did not make up all of the difference. Spending and utilization have been recovering, but could fall again if the current winter spike in COVID-19 causes hospitals to fill up and defer non-COVID-19 care, and people again put off elective care. We do not know what share of the spending and utilization skipped or delayed because of COVID-19 was necessary or unnecessary. There was a decline in cancer screenings and visits to manage chronic care but we also do not know if health outcomes suffered. These data will trickle in as studies are published, and will be critical to determining how much we can safely reduce health spending in the future. Historically external shocks to the system like recessions have had a larger impact on utilization and health spending than anything we have been able to do about costs in the health system. But COVID-19 is different; it’s a double shock to health spending. The COVID-19 economy, like any big recession, depresses utilization of health services because people have less money to spend for health care. But unlike typical recessions, COVID-19 also directly attacks the health system, filling up hospitals with COVID-19 patients, closing outpatient facilities and doctors offices, and causing people to defer or skip care for fear of becoming infected. It may be a long time before we see a reduction in health spending like this again.
[post_title] => COVID-19导致健康支出下降 [post_excerpt] => Drew Altman在其最新的Axios专栏中对冠状病毒大流行对国家卫生支出的影响进行了新的分析。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => covid-19-is-causing-health-spending-to-go-down [to_ping] => [pinged] => [post_modified] => 2020-12-02 05:46:00 [post_modified_gmt] => 2020-12-02 10:46:00 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=499019 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 496309 [post_author] => 36621681 [post_date] => 2020-11-17 05:00:34 [post_date_gmt] => 2020-11-17 10:00:34 [post_content] =>
A shorter version of this column has been published by Axios. Exit polls show that when 总统 Trump accused Democrats of exaggerating the gravity of the COVID -19 pandemic his supporters believed him. Trump supporters showed as they voted that they don’t see COVID-19 as a very urgent problem.  It leaves the Biden administration with a massive public re-education challenge in red America and among Trump supporters in every state. + For every voter group – whites, Blacks, urban, suburban and rural voters, voters with and without college degrees – about sixty percent of Biden voters said COVID-19 was a top issue driving their vote in the exit poll, which this year polled both voters who mailed in their ballots and voters who went to the polls. + But barely more than twenty percent of Trump voters named COVID-19 a top issue influencing their vote. + It was just the reverse for the economy.  8% of white Biden voters named the economy their top issue in exit polls, while 48% of white Trump voters did. An identical 8% of small town and rural Biden voters picked the economy while 48% of Trump voters did. This matters because COVID-19 is surging and it will be exceedingly difficult to get a handle on the pandemic as long as half the adult population – the folks who followed Trump - are COVID-19 deniers and dissenters.  We are also on the verge of seeing a vaccine become a reality. People who don’t believe COVID-19 is a serious threat will likely feel less compelled to get a vaccine. Over decades of messaging about HIV testing and treatment in our Greater Than AIDS program we have learned that there is no one-size-fits-all message. Messages need to be targeted to be effective with different groups. That means heavy use of digital media not PSA’s on television. And messengers have to be credible not just famous. Real people and real life stories ring true. Messages that direct people to local resources or actions they can take to protect themselves and their families are often most effective.  An important challenge is to emphasize disproportionate impact on people of color without furthering stigma or marginalization. The Biden administration will need to convince the deniers that COVID-19 and the economy are not an either or, and that getting a handle on COVID-19 is the route to building the economy. As Trump fades from the presidency more Americans who see COVID-19 denial as fealty to Trump may come around. SOURCE: 肯德基analysis of AP VoteCast, a survey of the American electorate conducted by NORC at the University of Chicago (conducted Oct. 27-Nov. 3).
[post_title] => 出口民意调查显示在Red America中需要对抗COVID-19拒绝 [post_excerpt] => Drew Altman在他最新的Axios专栏中分析了退出民意调查。尽管拜登选民将COVID-19列为重中之重,但特朗普的支持者仍然在很大程度上否认了流行病,否认了总统。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => the-exit-polls-show-the-need-to-confront-covid-19-denial-in-red-america [to_ping] => [pinged] => [post_modified] => 2020-11-17 06:45:15 [post_modified_gmt] => 2020-11-17 11:45:15 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=496309 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 491731 [post_author] => 36621681 [post_date] => 2020-10-21 06:04:02 [post_date_gmt] => 2020-10-21 10:04:02 [post_content] =>
In his latest Axios column, Drew Altman discusses how this election year health isn’t a single issue issue – but several –乔·拜登(Joe Biden)在所有这些方面都比特朗普总统更具优势,尽管反对ACA的反对派在特朗普的支持下仍然很受欢迎。
[post_title] => 乔·拜登(Joe Biden)在卫生保健问题上的重要领导 [post_excerpt] => 在Axios专栏中,Drew Altman讨论了选举年的健康状况不是一个单独的问题-- but several --乔·拜登(Joe Biden)在所有这些方面都比特朗普总统更具优势,尽管反对ACA的反对派在特朗普的支持下仍然很受欢迎。   [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => joe-bidens-big-lead-on-health-care-issues [to_ping] => [pinged] => [post_modified] => 2020-10-21 06:33:49 [post_modified_gmt] => 2020-10-21 10:33:49 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=491731 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [4] => WP_Post Object ( [ID] => 490123 [post_author] => 36621681 [post_date] => 2020-10-14 05:47:55 [post_date_gmt] => 2020-10-14 09:47:55 [post_content] =>
From a newly released 肯德基/The Undefeated national survey on race and health, Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic. “A vaccine distribution effort that is not coupled with a credible outreach effort in communities of color is likely to fall far short of reaching many of the people who are most at risk,” he writes.
[post_title] => 黑人美国人对冠状病毒疫苗更持怀疑态度 [post_excerpt] => 德鲁·奥特曼(Drew Altman)讨论了系统性种族主义如何导致令人震惊的不愿在包括高危人群在内的美国黑人中获得COVID-19疫苗的情况,以及它为结束大流行所带来的挑战。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => black-americans-are-more-skeptical-of-a-coronavirus-vaccine [to_ping] => [pinged] => [post_modified] => 2020-10-22 09:40:55 [post_modified_gmt] => 2020-10-22 13:40:55 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=490123 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [5] => WP_Post Object ( [ID] => 486505 [post_author] => 36621681 [post_date] => 2020-09-30 06:05:09 [post_date_gmt] => 2020-09-30 10:05:09 [post_content] =>
Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it'医院和门诊的支出主要解释了差异。他说,如果没有真正的痛苦和政治风险,这将是不可能发生的。
[post_title] => 毒品阿仁'这是美国在医疗保健上投入这么多的原因 [post_excerpt] => 德鲁·奥特曼(Drew Altman)在Axios上的专栏文章:美国现在的人均支出是其他富裕国家在医疗保健方面的支出的两倍。但是,尽管毒品成本无时无刻不在公众辩论中,'医院和门诊的支出主要解释了差异。他说,如果没有真正的痛苦和政治风险,这将是不可能发生的。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => drugs-arent-the-reason-the-us-spends-so-much-on-health-care [to_ping] => [pinged] => [post_modified] => 2020-10-22 09:41:28 [post_modified_gmt] => 2020-10-22 13:41:28 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=486505 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 6 [current_post] => -1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 501146 [post_author] => 36621681 [post_date] => 2020-12-15 05:00:41 [post_date_gmt] => 2020-12-15 10:00:41 [post_content] =>
A shorter version of this column has been published by Axios. There is a lot to be very worried about when it comes to vaccine hesitancy, but there are also reasons to be optimistic. The shares of hesitant groups that appear totally dug in are relatively modest for a new vaccine people have not seen administered safely in their communities, and many of the reasons people are reluctant to get vaccinated are remediable if they get more information from sources they trust. Four groups jump out from our new 肯德基COVID-19 Vaccine Monitor project as vaccine hesitant: Republicans and rural Americans – the Trump base, parroting the president’s COVID denialism; Black adults, and essential workers. In every case more members of each group says they will get the vaccine than say they will not. The shares who are currently hesitant range from 42% for Republicans to 33% for essential workers. Those are still big numbers, but it appears they can be reduced with more information. For example, 71% of Black adults who are now hesitant say it’s because they are worried about side effects. Once they learn they are mild and confirm that as people are vaccinated they may worry less. The same is true for the 50% of vaccine-hesitant Black adults who worry that they will actually get COVID from the vaccine, another top concern. 25% of Republicans currently say they will “definitely not” get the vaccine. But that leaves three quarters of Republicans who may get the vaccine under various circumstances: 28% of Republicans say they will get it “as soon as possible”; 33% want to “wait and see”; and 10% say they will get it “only if its required”. Among essential workers – a group that is a particularly important target of vaccination efforts because of their high risk of exposure to the virus – 28% say they will get the vaccine as soon as they can and 36% want to “wait and see”; another 14% say they’ll only get it if required for work or other activities, and 18% say they “definitely will not” get vaccinated. Hesitant essential workers have a variety of worries:  Half (51%) are worried about side effects, and a similar percentage don’t trust the government to make sure the vaccine is safe and effective (50%). There could be setbacks if there are adverse events that receive wide press coverage that spook already apprehensive groups and these will have to be managed well by public health leaders.  States will also need to allocate vaccine supply equitably to inner city and rural areas and assure distribution in those areas that is accessible for traditionally underserved populations. Distrust of government and institutions in communities of color will remain a real barrier. It will take effective messaging and information efforts utilizing credible messengers and digital communications techniques to reach these different groups, targeting their different worries about the vaccine. No one message or single messenger is likely to be effective. If those efforts are funded and implemented it does appear that real progress can be made to reduce hesitancy among the most resistant groups.
[post_title] => 疫苗犹豫可能真正的进步 [post_excerpt] => Drew Altman的Axios栏利用了新的KFF COVID-19疫苗监测仪提供的数据,以评估该国在疫苗犹豫方面所处的位置。 [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => real-progress-is-possible-on-vaccine-hesitancy [to_ping] => [pinged] => [post_modified] => 2020-12-22 14:00:22 [post_modified_gmt] => 2020-12-22 19:00:22 [post_content_filtered] => [post_parent] => 0 [guid] => //www.xskfr.cn/?post_type=perspective&p=501146 [menu_order] => 0 [post_type] => perspective [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 255 [max_num_pages] => 43 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 88d143b905ecf4f36b399aedd44b1a56 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )